Fig. 8
Strategies of engineered EVs for cancer therapy by targeting TME. Engineered EVs targeting the TME can be obtained from engineering parent cell or direct transformation of natural EVs. For parent cells, gene editing and co-incubation methods are the two primary approaches, whereas the drug loading and surface modification approaches of natural EVs are mainly based on the properties of utilized agents. Created with BioRender.com